Home  »  Stock   »  Akari Therapeutics Plc (AKTX) Stock: From Low to H...

Akari Therapeutics Plc (AKTX) Stock: From Low to High in 52 Weeks

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Akari Therapeutics Plc’s current trading price is -89.23% away from its 52-week high, while its distance from the 52-week low is 22.54%. The stock’s price range over this period has fluctuated between $0.14 and $1.61. The company, operating within the financial sector, had a trading volume of approximately 0.87 million for the day, which was noticeably higher than the average daily share volume of 0.49 million over the last 3 months.

Akari Therapeutics Plc (AKTX) stock is currently valued at $0.17. During the last session, the stock experienced a remarkable rise, reaching $0.2079 after opening at $0.1892. The stock briefly dropped to $0.1521 before ultimately closing at $0.19.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


The market performance of Akari Therapeutics Plc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.61 on 08/11/22, while the lowest value for the same duration was $0.14 on 03/31/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Akari Therapeutics Plc (AKTX) has experienced a quarterly decline of -52.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.34M and boasts a workforce of 9 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3170, with a change in price of -0.2965. Similarly, Akari Therapeutics Plc recorded 356,701 in trading volume during the last 100 days, posting a change of -63.10%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for AKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

AKTX Stock Stochastic Average

Today’s raw stochastic average for Akari Therapeutics Plc over the last 50 days is 22.08%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 27.41%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 31.76% and 42.29%, respectively.

AKTX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded a decrease of -63.10%. However, over the last six months, the performance has been stronger by -69.34%. The price of AKTX decreased -8.74% over the last 30 days. And in the last five days, it has fallen by -15.54%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts